Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Sep 07, 2021 8:45 AM - Sep 07, 2021 5:00 PM

(Singapore Standard Time)

DIA Asia 2021-The Evolution Of Clinical Trials And Regulatory Science In A Post-Pandemic Digital World In Asia

The timing is as per Singapore Time Zone

Session 3: Digital Technology Advances The Modernization Of Regulatory Science & Drug Development

Session Chair(s)

Fengyun(Vicky)  Han

Fengyun(Vicky) Han

Senior Director, Head of Regulatory Policy for Asia Pacific

Johnson & Johnson Pte. Ltd., Singapore

Rie  Matsui, RPh

Rie Matsui, RPh

Senior Director, International Labeling APAC

Pfizer R&D Japan G.K., Japan

Digital is a very dynamic and developing in a very fast manner, it has been wildly applied in almost everywhere and has been accelerated during the COVID-19 pandemic. the pharmaceutical industry and academia have been using many digital tools to accelerate the drug R&D and clinical trial development, and regulator is leveraging the digital technology to improve its drug review and supervision system etc. In this session, will focus on updating of digital technology to advance the regulatory system modernization, and the transitioning to e-labelling by using 2D barcode and structured format, and digital endpoint to facilitating the clinical trial development and cloud based system


Tomoko  Ohsawa, PhD

Formal implementation of e-labelling in Japan: Tomoko Ohsawa, PhD

Director of Office of Informatics and Management for Safety

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Tong  Guo

De-centralised Clinical Trial in China: Progress and Practice: Tong Guo

Executive Vice President

LinkDoc Technology (Beijing) Co. Ltd, China

Kai  Langel

Digital Endpoint Ecosystem & Protocols: Kai Langel

Senior Director, Strategy and Innovation, Global Regulatory Policy

Janssen, Spain

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.